Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

9.55
+0.27002.91%
Post-market: 9.600.0500+0.52%19:30 EDT
Volume:2.33M
Turnover:22.54M
Market Cap:1.64B
PE:-11.94
High:9.90
Open:9.56
Low:9.50
Close:9.28
52wk High:12.06
52wk Low:2.24
Shares:171.61M
Float Shares:156.49M
Volume Ratio:0.82
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7999
EPS(LYR):-0.8421
ROE:-57.72%
ROA:-34.10%
PB:6.66
PE(LYR):-11.34

Loading ...

Absci Updates Financial Calendar with Upcoming Q2 Results Webcast

Reuters
·
Jul 15

Absci director buys $149K in common stock

TIPRANKS
·
Jul 07

Absci Director Mary T Szela Acquires 12,900 Common Shares for $148,866

Reuters
·
Jul 07

AbSci (ABSI) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Jul 06

Absci is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 02

BTIG Remains a Buy on AbSci (ABSI)

TIPRANKS
·
Jul 01

Healthcare Stocks Have Become a Haven for Investors Ditching Tech

Dow Jones
·
Jun 27

Absci price target raised to $10 from $4.10 at Morgan Stanley

TIPRANKS
·
Jun 25

Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed?

Simply Wall St.
·
Jun 25

Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says

MT Newswires Live
·
Jun 25

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD) and AbSci (ABSI)

TIPRANKS
·
Jun 25

Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)

TIPRANKS
·
Jun 25

Absci is Maintained at Buy by BTIG

Dow Jones
·
Jun 25

Top Midday Gainers

MT Newswires Live
·
Jun 25

Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday

MT Newswires Live
·
Jun 24

U.S. Stocks on the Move-take-two, Wendy's, Absci

Reuters
·
Jun 24

Absci Rises on Positive Hair-loss Drug Data

Reuters
·
Jun 24

Absci Corp Shares up 14% Premarket After Co Reports Early-stage Trial Data from Its Ai-designed Hair Loss Drug

THOMSON REUTERS
·
Jun 24

Absci prices 13.5M shares at $7.41 in public offering

TIPRANKS
·
Jun 24

Absci reports Phase 1 data from human trial of ABS-201

TIPRANKS
·
Jun 24